#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infection in an immunocompromised host Hypersensitivity pneumonitis Neuronal ceroid lipofuscinosis Bronchiectasis Congenital disorder of glycosylation VEXAS syndrome Anti-myelin-associated glycoprotein antibodies positive Solitary fibrous tumour Bronchopulmonary aspergillosis Hypochondroplasia Adrenocortical carcinoma Nodal marginal zone B-cell lymphoma Hereditary motor and sensory neuropathy Nephropathy Hyperinsulinaemic hypoglycaemia More trials…

    Learn about Rare Diseases

    Myxofibrosarcoma – Treatment Angiosarcoma non-metastatic – Trials in Disease Breast angiosarcoma metastatic – Basic Information Idiopathic pulmonary fibrosis Fabry’s disease – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Basic Information Haemophilia A with anti factor VIII – Diagnostics Angiosarcoma metastatic – Treatment Encephalitis autoimmune – Basic Information Aicardi-Goutieres syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Linagliptin Hu5F9‐G4 Tucatinib Boserolimab Alrefimotide Rintatolimod Cortisone Alectinib Hydrochloride Cefotaxime NVG-2089 Sirexatamab Dordaviprone Vanzacaftor Casimersen Pimavanserin Tartrate Corline Heparin Conjugate Bi 764532 The-630 Olaparib Omp10 More therapies…

    Learn about Your Condition

    Limb reduction defect Type V hyperlipidaemia Hepatitis B Malabsorption Juvenile idiopathic arthritis Status epilepticus Open angle glaucoma Epileptic encephalopathy Acute leukaemia Autoimmune haemolytic anaemia Menopause Pneumothorax Electrocorticogram Encephalopathy neonatal Follicular lymphoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on Preventing Acute Kidney Injury After Heart Surgery Using Empagliflozin in Patients Undergoing Elective Cardiac Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Empagliflozin
    Spain

  • Study of oral lidocaine (ORE-001) to reduce abdominal discomfort and early satiety in patients with anorexia nervosa

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    Italy

  • Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain

  • Study on Stopping Allopurinol or Febuxostat in Gout Patients in Remission

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gout
    Investigated Drugs:
    • Allopurinol
    • Febuxostat
    France

  • Study on Bupropion Hydrochloride and Naltrexone Hydrochloride for Patients with Weight Regain After Bariatric Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic surgery
    • Obesity
    Investigated Drugs:
    • Naltrexone Hydrochloride
    • Bupropion Hydrochloride
    The Netherlands

  • Study on Verapamil and Exenatide for Adults with Type 1 Diabetes to Measure Changes in Beta Cell Mass

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Exenatide
    • Verapamil
    Austria France
Previous Page
1 … 28 29 30 31 32 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!